Please login to the form below

Not currently logged in
Email:
Password:

anti-CD3 mAb

This page shows the latest anti-CD3 mAb news and features for those working in and with pharma, biotech and healthcare.

Tiziana joins type 1 diabetes prevention field

Tiziana joins type 1 diabetes prevention field

Teplizumab is a mouse derived anti-CD3 mAb, and is administered intravenously. ... Now Tiziana is looking to rival Provention with the development of its own anti-CD3 mAB foralumab, which it says is the only entirely human anti-CD3 mAb.

Latest news

  • The impact of insulin

    Monoclonal antibodies. Tolerx and GSK are developing otelixizumab, an intravenous anti-CD3 humanised version of the monoclonal antibody (mAb) YTH-12.5. ... The US Juvenile Diabetes Research Foundation (JDRF) has provided $2m funding for a pivotal,

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics